There’s no human safety data on fisetin during pregnancy or breastfeeding. Here’s what actually exists (an animal study, not a human one) and why the standard advice is unanimous.
Fisetin is being studied as a senolytic for cancer survivors, but the active trials give it only after chemo ends, not during. Here’s why timing and a real enzyme-inhibition interaction matter.
Curious whether fisetin is doing anything for you? Here’s how to structure a personal n=1 protocol honestly — including what one biohacker’s bloodwork actually found.
Fisetin is poorly water-soluble. Learn why pairing it with dietary fat may improve absorption, what timing research suggests, and who should be cautious.
A clear-eyed look at fisetin side effects, drug interactions, and the significant gaps in human safety data for this senolytic flavonoid.
What fisetin senolytic supplement users actually report, from digestive discomfort and fatigue to bioavailability-related dosing confusion.
An honest, evidence-based review of fisetin safety for older adults: the senolytic hypothesis, preclinical findings, drug interactions, and real evidence limits
Comparing fisetin capsules and powder on dose flexibility, cost, convenience, and absorption. An honest guide to choosing the right supplement form.
Fisetin may inhibit CYP liver enzymes and interact with warfarin and blood thinners. Here’s what the evidence shows and who should be careful.
As we navigate the complexities of aging, the quest for interventions that genuinely promote healthspan continues to intensify. Fisetin, a
Fisetin is generally considered low-risk for most healthy adults at the doses studied in research, but the honest answer is
A clear breakdown of fisetin dosage — from preclinical and early human senolytic research to commercial supplement amounts — and why the gap matters.